Navigation Links
EPA to Improve Nanotechnology

The U.S. Environmental Protection Agency released its current thinking on whether a nanoscale material is a new or existing chemical substance under the Toxic Substances Control Act (TSCA).

In the document, TSCA Inventory Status of Nanoscale SubstancesGeneral Approach, EPA states that it will maintain its practice of determining whether nanoscale substances qualify as new chemicals under TSCA on a case-by-case basis.

According to former EPA official and Project on Emerging Nanotechnologies (PEN) senior advisor J. Clarence Davies, The agencys current practice is inadequate to deal with nanotechnology. It is essential that EPA move quickly to recognize the novel biological and ecological characteristics of nanoscale materials.

It can do this only by using the new uses provisions of TSCA, a subject not mentioned in the EPAs inventory document. With the approach outlined by EPA and because of the weaknesses in the law, the agency is not even able to identify which substances are nanomaterials, much less determine whether they pose a hazard.

Project on Emerging Nanotechnologies science advisor Andrew Maynard underlined that EPAs approach ignores the scientific research evidence to date that different nanostructures with the same molecular identity present different hazards.

Nanotechnology is a rapidly growing sector of the economy that will represent an estimated 2.6 trillion dollars in manufactured goods by 2014, or about 15 percent of global manufactured goods output.

In addition to the TSCA document, the agency issued papers for public comment pertaining to a proposed voluntary industry Nanoscale Materials Stewardship Program (NMSP)an effort to encourage industry to provide the agency on a voluntary basis with scientific information about the risk management practices now used by manufacturers of existing nanomaterials.

Starting the Stewardship program will be a positive s tep toward filling in some of the information gaps facing the agency. But there should be an interplay between modifying TSCA, such as promulgating a significant new use rule for nanomaterials, and the voluntary program.

A sequential approach will leave nanomaterials unregulated for far too long, and will also be less productive than if the two efforts proceed in tandem, said Davies.

This voluntary program for nanomaterials is already behind schedule. The British government put in place a Voluntary Reporting Scheme in September 2006, and appears to be on a faster track to develop appropriate controls and to give a predictable nanotechnology regulatory environment for industry and consumers, he continued.

The first generation of nanotechnology applications and products is here. In an inventory maintained by the Project on Emerging Nanotechnologies, there are now over 500 manufacturer-identified nanotechnology consumer products being sold, said Dr. Maynard.

This figure does not include nanotechnology products on the market but not identified as such, or the hundreds of nano raw materials, intermediate components, and industrial equipment items used by manufacturers today. In addition, second generation usesin electronics, sensors, targeted drugs and active nanostructureshave already begun.

In May 2007, Davies authored the first in-depth analysis of EPAs nano-tech readiness, EPA and Nanotechnology: Oversight for the 21st Century.

The report recommends more than 25 actions that need to be takenby EPA, Congress, the President, the National Nanotechnology Initiative, and the nanotech industryto improve the oversight of nanotechnologies.

In an opinion piece published in the Boston Globe on Saturday (July 7, 2007), Davies and EPAs first administrator William Ruckelshaus wrote, Todays smallest materials pose a big opportunity and huge challenge for the Environmental Protection Age ncy.

But what do we know about nanotechnology, about its effects on human health and the environment" Not much. What are we doing to get these answers" Not enough.

Can the existing regulatory system protect the public from potential problems with nanotechnology" Not adequately. It is time for the EPA to step into the breach and develop a research and regulatory framework for nanotechnology that helps us achieve its promise while avoiding or greatly minimizing any possible dangers.




'"/>




Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Steps To Improve Quality Of Plant-Based Drugs
3. Almonds Improve Cholesterol
4. How to Improve Life Expectancy
5. Sage Improves Memory
6. Protein said to Improve Muscle Loss
7. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
8. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
9. Vitamin B12 Supplements Found To Improve Memory
10. A Loving Relationship Found To Improve Heart Health
11. Fish Found To Improve Fetal Growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and ... the ultimate weight loss and wellness program, at their world headquarters of Omni La ... immediate and long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... continuity to its innovative Unified Instance Manager architecture, meeting the needs of ... new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... 2016 Research and Markets has announced the addition ... to their offering. ... The report provides separate comprehensive analytics for ... and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:12/7/2016)... -- "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by ... drug in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... patent on Lantus expired in 2014. Lantus is the brand name ...
Breaking Medicine Technology: